Global ConSeptS – Consultancy
Global ConSeptS – Consultancy is an independent technical consultancy company that was established in 2008. The company specialises in aseptic processing and Quality by Design projects specific to the global bio-pharmaceutical industry. Our approach is pragmatic and to-the-point. You are our customer and we want you to get the best technical solution rather than a theoretical proposal. Although today Global ConSeptS is a one-man company, we want you to be best served. That is why we closely work together with other competent consultancy companies to provide you the best quality for your projects and assure you on-time delivery.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Genesis Research Group
Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
How we applied user-led design thinking in the ER setting to improve patient care
White Papers and Resources | March 7, 2018 | Inizio
The challengeOur client needed to identify the key delivery-device attributes for an antibiotic topical treatment used to combat a group of infections typically affecting young children. Current treatment is a...
Research conducted by Research Partnership published in leading medical journal
White Papers and Resources | March 7, 2018 | Inizio
Findings from a study conducted by Research Partnership have recently been published in the ‘Supportive Care in Cancer’ journal
The Lucid Festival of Magic
Videos and Podcasts | March 6, 2018 | Lucid Group Communications Limited
Lucid Group threw a spellbinding event to celebrate eleven years of transforming lives with their standout new branding taking centre stage.
The Periodic Table of Healthcare Communications 2018
White Papers and Resources | March 6, 2018 | An agency called Owen
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing.
Managing local population needs is key for the NHS
White Papers and Resources | March 6, 2018 | Wilmington Healthcare
Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore population-based planning in the NHS and what this means for pharma
Lighthouse Medical Communications US bolster their senior scientific team
Press Releases | March 2, 2018 | Lucid Group Communications Limited
Lighthouse Medical Communications US, part of the award-winning Lucid Group of companies, is pleased to announce the appointment of Marc Pondel, PhD as Executive Medical Science Director. Marc will oversee...
Vivid Medical Communications Supports the 10th Anniversary of Rare Diseases Day 2018
Press Releases | February 28, 2018 | Lucid Group Communications Limited
Vivid Medical Communications – a newly created rare diseases specialist agency and part of the successful Lucid Group of companies – is a proud supporter of Rare Diseases Day 2018.
Rare Disease Day 2018: Five things you should know about rare diseases.
Press Releases | February 28, 2018 | Porterhouse Medical Group
To help raise awareness for Rare Disease Day, Porterhouse Medical describes five interesting facts about rare diseases
Six Factors to Consider When Designing Advisory Boards
White Papers and Resources | February 27, 2018 | Six Degrees Medical Consulting
Designing engaging, efficient and effective advisory boards is a complex task. You need to convince key opinion leaders from around the world to take time out of their busy schedules...
Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
White Papers and Resources | February 23, 2018 | Inizio
Hiding between the lines of any company’s ledgers is an intangible asset, invisible to most auditors, but with the potential to have a very real impact on bottom line. Pharma...